Inhalable aztreonam for treatment and prevention of...

Details Inhalable aztreonam for treatment and prevention of... Inhalable aztreonam for treatment and prevention of...

A - Human Necessities

61

K

A61K 31/427 (2006.01) A61K 9/19 (2006.01) A61P 11/00 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2708703

A method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug reistant Pseudomonas aeruginosa, using a concentrated formulation of aztreozonam, or a pharmaceutically acceptable salt thereof, delivered as an aerosol or dry powder formulation.

Affiliated with

Also associated with

Rating

Inhalable aztreonam for treatment and prevention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhalable aztreonam for treatment and prevention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhalable aztreonam for treatment and prevention of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1350439